Net Cash Provided by (Used in) Operating Activities |
-4.95M |
USD |
-1299% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
153K |
USD |
-69.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-1.83M |
USD |
-199% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
600M |
shares |
|
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
47.1M |
shares |
+711% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-6.63M |
USD |
-1320% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.61M |
USD |
+207% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
2M |
USD |
+59.6% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
2M |
USD |
+59.6% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
20M |
shares |
+1900% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
225M |
USD |
+3114% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Share-based Payment Arrangement, Expense |
1.7M |
USD |
|
Q1 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |